Aviragen Therapeutics Tops Q2 EPS by 11c
- ByInvesting.com-
Aviragen Therapeutics (AVIR) reported Q2 EPS of ($0.38), $0.11 better than the analyst estimate of ($0.49).
Symbol | Exchange | Currency |
---|
Aviragen Therapeutics (AVIR) reported Q2 EPS of ($0.38), $0.11 better than the analyst estimate of ($0.49).
Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Healthcare, Utilities and Oil & Gas sectors led shares higher. At the close in NYSE, the Dow...
By Dhirendra TripathiInvesting.com -- Stocks rose on Tuesday on strong results from Johnson & Johnson and others that whet investors’ risk appetites.The S&P 500 was...
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, a novel antiviral agent that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 that is in Phase I/IIa clinical trial for the treatment of chronic hepatitis C; and AT-889, an investigational, second-generation nucleoside pyrimidine prodrug and other compounds for the treatment of respiratory syncytial virus. It has a Roche License Agreement with F. Hoffmann-La Roche Ltd and Genentech, Inc. for development and commercialization related to AT-527 outside of the United States. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Sell | Sell | Buy | Sell |
Technical Indicators | Sell | Strong Buy | Strong Sell | Buy | Strong Sell |
Summary | Neutral | Neutral | Strong Sell | Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
65.22 | 65.35 | 64.71 | +0.34 | +0.52% | 6.49M | NYSE | |||
18.55 | 20.81 | 16.16 | -4.53 | -19.63% | 136.95M | NASDAQ | |||
367.99 | 369.94 | 362.75 | +3.30 | +0.90% | 1.96M | NYSE | |||
120.86 | 121.68 | 119.56 | +0.54 | +0.45% | 15.38M | NASDAQ | |||
245.17 | 246.48 | 239.28 | +4.02 | +1.67% | 5.27M | NASDAQ | |||
7.66 | 7.72 | 7.63 | +0.03 | +0.39% | 4.19M | NASDAQ | |||
53.55 | 53.72 | 53.04 | -0.21 | -0.39% | 10.31M | NYSE | |||
83.79 | 84.39 | 82.64 | +1.65 | +2.01% | 78.78K | NYSE | |||
173.05 | 175.14 | 171.58 | -2.29 | -1.31% | 4.23M | NYSE | |||
0.406 | 0.427 | 0.303 | +0.122 | +42.90% | 152.61M | NASDAQ | |||
266.58 | 267.36 | 265.42 | -0.24 | -0.09% | 1.59M | NYSE | |||
48.58 | 49.52 | 48.38 | -0.69 | -1.40% | 18.48M | NYSE | |||
68.14 | 68.16 | 67.63 | +0.45 | +0.66% | 215.05K | NYSE | |||
37.13 | 37.23 | 35.97 | +1.73 | +4.89% | 10.71M | NYSE | |||
94.02 | 99.91 | 93.22 | -10.40 | -9.96% | 5.16M | NYSE |